In our multivariable model, we observed a suggestive trend with higher risks among survivors receiving etoposide within the HSCT with TBI group.
← all excerpts
Increased risk of subsequent neoplasm after hematopoietic stem cell transplantation in 5-year survivors of childhood acute lymphoblastic leukemia.
1
—
—